Title of article :
Type of Pegylated Interferon Matters: Another Milestone in the Treatment of Hepatitis C Virus Infection
Author/Authors :
Kumar Singal, Ashwani Division of Gastroenterology, Department of Internal Medicine - University of Texas Medical Branch - Galveston - Texas, USA
Abstract :
Hepatitis C virus (HCV) infects 170
million people worldwide (1). The
infection becomes chronic in 85%–90% of cases
with potential to cause cirrhosis, end-stage liver
disease, and hepatocellular carcinoma (HCC) (2).
Keywords :
C virus , HCV , Infection , PEG
Journal title :
Astroparticle Physics
